Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 1026 - 1050 of 2016 in total
Investigational
Recombinant human lecithin:cholesterol acyltransferase is under investigation in clinical trial NCT03578809 (A Study to Evaluate the Safety and Efficacy of MEDI6012 in Acute ST Elevation Myocardial Infarction).
Investigational
Chlorotoxin I-131 is investigated in clinical trials for treating brain cancer. Chlorotoxin I-131 binds to and reduces the activity of a matrix metalloproteinase (MMP) that regulates functioning of the chloride channels on cell membranes. Chlorotoxin is a small 36-amino-acid peptide that selectively binds to glioma cells but not normal brain...
Investigational
Experimental
Matched Mixtures name: … LUXNID 2/200 MCG INHALASYON IÇIN TOZ IÇIEREN KAPSÜL,60 KAPSÜL ... LUXNID 2/400 MCG INHALASYON IÇIN TOZ IÇEREN BLISTER ,60 DOZ ... POENA 2/400 MCG İNHALASYON İÇİN TOZ İÇEREN BLİSTER, 60 DOZ …
Matched Products: … AIRWAY 1 MCG INHALASYON IÇIN TOZ IÇEREN BLISTER, 60 DOZ ... AIRWAY 2 MCG INHALASYON IÇIN TOZ IÇEREN BLISTER, 60 DOZ ... AIRWAY 4 MCG INHALASYON IÇIN TOZ IÇEREN BLISTER, 60 DOZ …
Investigational
Levodropropizine is under investigation in clinical trial NCT01573663 (A Drug-Drug Interaction Study of Ambroxol and Levodropropizine).
Investigational
Matched Products: … LEVOPRONT SYRUP 60 mg/10 ml ... LEVOPRONT 60 MG TABLET ,10 TABLET ... İSODOS 60 MG/5 ML ŞURUP, 1 ADET …
Dapoxetine is a selective serotonin reuptake inhibitor, for the treatment of premature ejaculation. In a phase II proof-of-concept study conducted by PPD, dapoxetine demonstrated a statistically significant increase in ejaculatory latency when compared to placebo. Alza submitted a NDA to the FDA for dapoxetine for the treatment of premature ejaculation...
Investigational
Matched Products: … LONGRIDE 60 MG ... PRILIGY 60 MG FILM COATED TABLETS ... Priligy 60 mg Filmtabletten …
Experimental
Matched Products: … DURISAL 60 ML SUSPANSIYON ... FURIL 200 MG 60 ML SUSPANSIYON ... ENFURYL 200 MG/5 ML SÜSPANSİYON, 60 ML …
LM-609 (Vitaxin) is an artificial antibody that targets a protein on the surface of newly forming blood vessels, as well as on certain tumors. In addition to cancer, the protein has been implicated in bone destruction in rheumatoid arthritis and the inflammatory process in psoriasis.
Investigational
N6022 has been used in trials studying the treatment of Asthma and Cystic Fibrosis.
Investigational
E6005 has been used in trials studying the treatment of Atopic Dermatitis.
Investigational
Experimental
Investigational
Matched Salts cas: … 117552-78-0
Matched Products: … X-VEN 500 MG KAPSÜL,60 ADET ... DOXIUM 500 MG KAPSUL, 60 ADET ... MODET 500 MG KAPSUL, 60 ADET …
AV608 is a NK-1 antagonist. It is developed for the treatment of Social anxiety disorder (SAD), irritable bowel syndrome (IBS) and overactive bladder (OAB).
Investigational
RSV-604 is under investigation in clinical trial NCT00416442 (Safety, Tolerability and Pharmacokinetic Study of Single and Multiple Intravenous Doses of RSV604 in Healthy Subjects.).
Investigational
Experimental
Investigational
Matched Salts cas: … 26095-59-0
Matched Products: … EKSPAZ 40 MG FILM TABLET, 60 ADET ... SPADIS 40 MG TABLET, 60 ADET ... SOPRAMIL 40 MG FILM TABLET, 60 ADET …
Experimental
Urapidil has been investigated for the treatment of Hypertension During Pre-Eclampsia.
Investigational
Matched Products: … EBRANTIL 60 ... EBRANTIL 60 MG ... Ebrantil retard 60 mg - Kapseln …
Experimental
Matched Products: … BI-SOL LOSYON, 60 ML ... BI-SOL FORT SAMPUAN, 60 ML …
CHF6001 has been used in trials studying the treatment of Asthma and Chronic Obstructive Pulmonary Disease.
Investigational
Investigational
ALLO-605 is an allogeneic turbo chimeric antigen receptor (Turbocar) T Cell therapy targeting B Cell maturation antigen (BCMA).
Investigational
NBI-6024 is an altered peptide ligand that is designed to cause an immune response which result in preservation of beta-cell function and endogenous insulin production.
Investigational
A recombinant AAVrh74 gene therapy expressing the dysferlin transgene under control of a muscle-specific promoter (rAAVrh74.MHCK7.DYSF.DV).
Investigational
Saruparib is under investigation in clinical trial NCT06380751 (Saruparib (AZD5305) Plus Camizestrant Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in Hr-positive, Her2-negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or Palb2m Advanced Breast Cancer).
Investigational
Matched Description: … With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in Hr-positive, Her2-negative (IHC 0, …
Investigational
Displaying drugs 1026 - 1050 of 2016 in total